Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BY-NC 4.0Clinical Pharmacology and Therapeutics

Navigating the Role of Clinical Pharmacists in Integrative Oncology Care Teams: Time to Create Higher Training and Practice Standards

  • Eran Ben‐Arye1,2
  • Sunita Vohra3
  • Noah Samuels4
  • Alexandre Chan5,6
6 affiliations
  1. 1The Ruth and Bruce Rappaport Faculty of Medicine, Technion‐Israel Institute of Technology Haifa Israel
  2. 2Integrative Oncology Program, The Oncology Service, Lin, Carmel, and Zebulun Medical Centers Clalit Health Services Haifa Israel
  3. 3Department of Pediatrics and Psychiatry Faculty of Medicine & Dentistry University of Alberta Edmonton Alberta Canada
  4. 4Center for Integrative Complementary Medicine, Shaare Zedek Medical Center Faculty of Medicine, Hebrew University of Jerusalem Jerusalem Israel
  5. 5Health Services Research and Population Health Duke‐NUS Graduate Medical School Singapore Singapore Singapore
  6. 6Division of Cancer Survivorship and Wellness National Cancer Centre Singapore Singapore
Read full textPDFDOICite

Abstract

Integrative oncology (IO) programs are committed to offer evidence‐based complementary medicine within conventional cancer care, addressing quality of life‐related concerns. As part of a multidisciplinary team, clinical pharmacists provide guidance on potential effectiveness and safety of herbal supplement use, identifying potential toxicities and herb–drug interactions. In this commentary, we discuss the need to establish clinical competencies based on a structured training syllabus addressing patients' preferences and expectations, while ensuring safe IO practices.

Related

  1. Beyond class assumptions: a clinical decision framework for navigating drug-supplement interactions in oncology
    Candy Tsourounis
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyFrontiersCrossrefDOAJ
  2. Understanding Patient Perspectives and Acceptability of Integrative Naturopathic Oncology in Metastatic Cancer.
    Sara Izadi-Najafabadi, Adeleke Fowokan, Gurdev Parmar
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Reconfiguring clinical pharmacists’ roles under China’s DRG payment system: perspectives from clinical pharmacists and physicians in multidisciplinary teams
    Juan Fu, Xiang Gao, Qingran Sun +2
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMCPMC
  4. Clinical decision support tool evaluation: Correction of direct oral anticoagulant dosing errors by clinical pharmacists and physicians
    Anish Saraswat, Shawna N. Smith, Michael P. Dorsch +5
    Research and Practice in Thrombosis and HaemostasisPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  5. Reasons for encounter and recommended interventions in an interprofessional integrative oncology counseling program in outpatient care: a mixed-methods analysis of 1,693 consultation letters.
    Andreas Schmitt, Regina Stolz, Holger Mauch +6
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{benarye2026navigating,
  title = {{Navigating the Role of Clinical Pharmacists in Integrative Oncology Care Teams: Time to Create Higher Training and Practice Standards}},
  author = {Eran Ben‐Arye and Sunita Vohra and Noah Samuels and Alexandre Chan},
  journal = {Clinical Pharmacology and Therapeutics},
  year = {2026},
  month = nov,
  doi = {10.1002/cpt.70559},
  url = {https://doi.org/10.1002/cpt.70559},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Navigating the Role of Clinical Pharmacists in Integrative Oncology Care Teams: Time to Create Higher Training and Practice Standards
AU  - Eran Ben‐Arye
AU  - Sunita Vohra
AU  - Noah Samuels
AU  - Alexandre Chan
PY  - 2026
DA  - 2026/11/04
JO  - Clinical Pharmacology and Therapeutics
DO  - 10.1002/cpt.70559
UR  - https://doi.org/10.1002/cpt.70559
AB  - Integrative oncology (IO) programs are committed to offer evidence‐based complementary medicine within conventional cancer care, addressing quality of life‐related concerns. As part of a multidisciplinary team, clinical pharmacists provide guidance on potential effectiveness and safety of herbal supplement use, identifying potential toxicities and herb–drug interactions. In this commentary, we discuss the need to establish clinical competencies based on a structured training syllabus addressing patients' preferences and expectations, while ensuring safe IO practices.
SN  - 0009-9236
SN  - 1532-6535
ER  -